Advertisement Harvard University and Oxford Nanopore sign licensing agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Harvard University and Oxford Nanopore sign licensing agreement

Harvard University's Office of Technology Development and Oxford Nanopore Technologies have signed an agreement to progress nanopore science by integrating Harvard discoveries with technology in development at Oxford Nanopore.

Under the terms of this agreement with Harvard, Oxford Nanopore has exclusive rights to develop and commercialize a number of nanopore technological breakthroughs developed in the laboratories of three investigators at Harvard and their collaborators at the University of California Santa Cruz and the National Institute of Standards and Technology, an agency of the US Department of Commerce.

Oxford Nanopore will also support fundamental nanopore research at Harvard, facilitating further advancement of the field and generating opportunities for further evolutions of nanopore sequencing technology.

Gordon Sanghera, CEO of Oxford Nanopore, said: “Through this partnership and agreements with other prestigious institutions, Oxford Nanopore takes the leading position in transforming nanopores from science into technologies that will benefit researchers and people everywhere.”